====== Princess Chulabhorn International Science Congress (PC) Program ====== ===== The Seventh Princess Chulabhorn International Science Congress (PC VII)===== ===== Congress Theme: Cancer: From Basic Research to Cure ===== ** 29 November - 3 December 2012 \\ Shangri-La Hotel, Bangkok, Thailand ** The congress was held to commemorate **the seventh cycle (84 years) of the birth of His Majesty King Bhumibol Adulyadej and also the eightieth birthday of Her Majesty Queen Sirikit**, an auspicious occasion and a national celebration in which scientists from countries throughout the world were invited to share. The Congress welcomed a total of 97 invited speakers from 19 countries and over 700 participants from 32 countries. The theme of the seventh Princess Chulabhorn International Science Congress reflects the concern at the increasing incidence of deaths worldwide from cancer, which has become an urgent global issue affecting everyone, either directly or indirectly. It has been predicted that over the next 10 years as many as 84 million people will die of cancer and more than 70% of them in the developing world. There is therefore an urgent need for international collaboration in all areas of basic, translational and clinical research to combat this deadly disease. Her Royal Highness Princess Chulabhorn Mahidol thus deemed it important to organize this congress as a forum for presenting the latest development in all areas of cancer research including cancer etiology and molecular mechanisms, strategies for cancer prevention, early detection and diagnosis as well as therapeutic interventions, all of which are crucial in our battle to overcome cancer. In her keynote address in the opening ceremony of the congress, Her Royal Highness Princess Chulabhorn emphasized that the environment and human lifestyles are major risk factors for cancer, with more than 70% of all cancer cases caused by environmental and lifestyle factors that may be preventable. This was one of the main themes running through many of the presentations in the scientific program of the congress. The program, which spanned 5 days, featured a Nobel Laureate Lecture entitled “Cancer: The Genomic Era Arrives”, given by John Michael Bishop from the U.S.A., a total of 9 Plenary Lectures and 1 Closing Lecture, 12 Symposia and a Closing Session on Challenges and Opportunities: Cancer Treatment from Bench to Bedside. In all there were 207 poster presentations displaying research conducted by congress participants. The program of the closing ceremony of the congress, in addition to the closing lecture entitled “Future Practice of Medicine” delivered by Michael Rosenblatt from the U.S.A., featured the signing of a landmark collaboration agreement between the Chulabhorn Research Institute and the Center for Cancer Research, National Cancer Institute, U.S.A. The signing ceremony was followed by the presentation of the Princess Chulabhorn Gold Medal Award to 3 distinguished recipients: Dr. John H. Duffus from the U.K., Professor Minoru Isobe from Japan, and Professor Gerald N. Wogan from U.S.A. In her closing speech, Her Royal Highness Princess Chulabhorn emphasized that in order to address a complex disease like cancer, there is a need to pool resources in order to optimize opportunities for developments in prevention, diagnosis and treatment, through cooperation among research scientists, physicians, public health personnel and policy makers. Her Royal Highness went on to state that the presentations, discussions and meetings conducted during the congress have pointed the way to how breakthroughs in cancer therapy might be achieved. Their realization will bring immediate benefits to sufferers in countries throughout the world. Her Royal Highness expressed her thanks to all the speakers whose participation and professional excellence had contributed to the success of the congress. In closing, Her Royal Highness announced the theme for the next Princess Chulabhorn International Science Congress to be held in 2016, which will be **“Environmental Health: Interlinkages among the Environment, Chemicals and Infectious Agents”.** {{:academic:pc:pc7:pc7_01.jpg|}}{{:academic:pc:pc7:pc7_02.jpg|}}{{:academic:pc:pc7:pc7_03.jpg|}} ==== The Princess Chulabhorn Gold Medal Award ==== Professor Dr. Her Royal Highness Princess Chulabhorn established the **“Princess Chulabhorn Gold Medal Award”** to honor world-renowned individuals or organizations whose work has received international acclaim. Importantly, recipients shall have provided important and sustained support to the advancement of science in developing countries. In 2012, the award presentation was a special ceremony held at the close of the Seventh Princess Chulabhorn International Science Congress. **The awardees were:** **Dr. John H. Duffus,** Director of the Edinburgh Centre for Toxicology, U.K. Dr. Duffus’ involvement in environmental toxicology began in 1973, when he was asked to advise on prevention of toxic hazards for fish and human consumers from the possible discharge of metals near fishing grounds. He also introduced new courses in toxicology at the Heriot-Watt University. The subsequent publication of his pioneering textbook on “Environmental Toxicology” led to an invitation from the WHO Regional Office for Europe to become their main consultant on Manpower Development for Chemical Safety under the International Programme on Chemical Safety (IPCS), at which time he prepared a strategy for developing courses and curricula in toxicology, and organised short international courses in toxicology and risk assessment in different countries, including Thailand. Through his significant contributions to training programs organized by CRI, his work in environmental toxicology has had an extensive and lasting impact on human resources development and sustainable development in South East Asia. During his distinguished career in Toxicology, Dr. Duffus has authored or contributed significantly to more than 200 major publications and has received extensive support from the UK Research Councils and the European Commission, while contributing to IPCS, WHO, and UNEP Chemicals. He is currently active in developing approaches to risk assessment of toxicity of metals that take into account their chemical speciation. **Professor Minoru Isobe,** Professor Emeritus of Nagoya University and Chair Professor, National Tsing Hua University, Taiwan. Professor Isobe is recognized worldwide as a leading authority in Organic Chemistry in general, and Organic Synthesis in particular, as well as Natural Products Chemistry and Bioorganic Chemistry. His most notable fields of research are the total synthesis with stereo chemical control of very complex natural products and bioorganic chemistry of bioluminescence, marine toxins, insect hormones, ion selective ionophore, and chemical biology of molecular interaction between natural products and target proteins. He is the author of over 300 original research articles and more than 80 review articles and books, and has long been involved with the International Union of Pure and Applied Chemistry (IUPAC), including as IUPAC Division President of Organic & Biomolecular Chemistry, and IUPAC Task Group Chair of a project on “Strategic Planning for a new East Asian Network for Organic Chemistry”. Since 1987, Professor Isobe has made outstanding contributions to human resource development in chemical science for Thailand, training many Thai Ph.D. students, postdoctoral fellows and short term visiting scientists, including many from CRI. He is the initiator and founding member of the very successful Asian Core Program: Cutting Edge Organic Chemistry in Asia, and has participated in 6 out of 7 occasions in the Princess Chulabhorn International Science Congress Program. He is also a visiting professor at the Chulabhorn Graduate Institute. **Professor Gerald N. Wogan**, a Visiting Professor, Department of Environmental Health, Johns Hopkins University, and Senior Research Fellow, Laboratory of Human Carcinogenesis, U.S. National Cancer Institute, National Institutes of Health. Professor Wogan’s seminal contribution to science and human health is the development of a new paradigm for demonstrating the impact of an environmental contaminant on human health. He followed that paradigm to its ultimate end, which is the prevention of the toxic effect in a human population. With his longtime collaborator, Dr. George Buchi, he was able to isolate, purify and determine the structure of aflatoxin, and subsequent studies on metabolism and carcinogenicity allowed the characterization of the structure of the DNA adducts, which could be used as biomarkers of exposure. These studies led to the discovery that aflatoxin was a major cause of liver cancer in Asia and Africa. This paradigm for aflatoxin became widely adopted as the model for conducting human epidemiology studies on environmental toxins. Professor Wogan was elected in 1977 to the US National Academy of Sciences, and is the author of over 200 key scientific research papers. He is a greatly revered adviser to CRI, with his first contribution to the development of research in Thailand being the MIT-Thai program founded in 1977 to address the health problem of liver cancer that affected much of the developing world. He has also been instrumental in making it possible for Thai graduate students to receive research training at MIT, John Hopkins or Harvard laboratories as part of their postgraduate education.